Akili (AKLI) News Today → **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (From Huge Alerts) (Ad) Free AKLI Stock Alerts $0.42 -0.01 (-1.72%) (As of 03:40 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | msn.comAkili reports Q1 results; suspends outlookMay 14, 2024 | investorplace.comAKLI Stock Earnings: Akili Beats EPS, Misses Revenue for Q1 2024May 14, 2024 | businesswire.comAkili Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 12, 2024 | americanbankingnews.comAkili (NASDAQ:AKLI) Trading Down 0.5%May 12, 2024 | americanbankingnews.comAkili, Inc. (NASDAQ:AKLI) Short Interest UpdateMay 3, 2024 | bizjournals.comTherapeutic video game maker Akili lays off workers for third time in 16 monthsApril 30, 2024 | investorplace.comWhy Is Akili (AKLI) Stock Up 68% Today?April 30, 2024 | businesswire.comAkili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial ResultsApril 30, 2024 | marketbeat.comTrading was temporarily halted for "AKLI" at 07:04 AM with a stated reason of "News pending."March 11, 2024 | bizjournals.comDigital medicine maker Akili slashed executive pay in 2023March 3, 2024 | finance.yahoo.comAkili Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagMarch 1, 2024 | markets.businessinsider.comAkili (AKLI) Gets a Buy from TD CowenFebruary 29, 2024 | businesswire.comAkili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateFebruary 28, 2024 | benzinga.comPreview: Akili's EarningsFebruary 28, 2024 | investing.comAkili's ADHD digital therapy seeks Japan approvalFebruary 27, 2024 | msn.comCrude Oil Gains 1%; US New Home Sales Increase In JanuaryFebruary 27, 2024 | businesswire.comPureTech Founded Entity Akili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx ® for Pediatric ADHD Patients in JapanFebruary 26, 2024 | investorplace.comWhy Is Akili (AKLI) Stock Up 110% Today?February 26, 2024 | msn.comWhy Is Prescription Digital Medicine-Focused Akili Stock Trading Over 100% On Monday?February 26, 2024 | seekingalpha.comAkili's ADHD device submitted for Japanese approval, stock rallies 130%February 26, 2024 | finance.yahoo.comAkili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in JapanFebruary 26, 2024 | businesswire.comAkili Announces Positive Results from Shionogi's Phase 3 Clinical Trial of Localized Version of Akili's EndeavorRx® for Pediatric ADHD Patients in JapanFebruary 21, 2024 | finance.yahoo.comAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesFebruary 21, 2024 | businesswire.comAkili Announces Release Date for Fourth Quarter and Full Year 2023 Financial Results, Provides Investor Communications and Board and Corporate Governance UpdatesJanuary 15, 2024 | finance.yahoo.comAkili, Inc. (AKLI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?January 8, 2024 | bbc.comAkli Tadjer: French writer meets students in school race rowDecember 26, 2023 | cnet.comWhat to Know About EndeavorRX, the Video Game to Treat ADHDDecember 21, 2023 | finance.yahoo.comAkili, Inc. (AKLI) Upgraded to Buy: Here's What You Should KnowDecember 21, 2023 | bizjournals.comThe Petri Dish: ADHD-treating videogame cleared for teens, CRISPR exec resignsDecember 19, 2023 | morningstar.comAkili Inc Ordinary SharesDecember 18, 2023 | finance.yahoo.comEndeavorRxⓇ, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17November 15, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN) and Akili (AKLI)November 14, 2023 | morningstar.comAkili Inc Ordinary Shares AKLINovember 13, 2023 | finance.yahoo.comAkili, Inc. (NASDAQ:AKLI) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finanznachrichten.deAkili Reports Third Quarter 2023 Financial Results and Provides Business UpdateOctober 14, 2023 | tmcnet.comEmployees with ADHD Aren't Reaching Their Full Potential at Work, Akili Study FindsOctober 12, 2023 | finance.yahoo.comEmployees with ADHD Aren’t Reaching Their Full Potential at Work, Akili Study FindsOctober 6, 2023 | finance.yahoo.comAkili Announces Leadership TransitionOctober 5, 2023 | markets.businessinsider.comAnalyst Affirms Buy Rating for Akili, Emphasizing Shift to OTC Strategy and Potential Strategic PartnershipsOctober 2, 2023 | markets.businessinsider.comBuy Rating on Akili’s Stock: Strategic Shift, Cash Management, and Anticipated FDA Clearances Bolster OptimismSeptember 21, 2023 | stockhouse.comAkili Releases EndeavorOTC(TM) on Android(TM) Devices, Expanding Treatment Access for Millions of Adults with ADHDSeptember 15, 2023 | finance.yahoo.comInsider Sell: CEO Martucci Walter Edward II Sells 2,353 Shares of Akili IncSeptember 13, 2023 | finance.yahoo.comAkili Announces Business Transformation, Focusing on Non-prescription ModelSeptember 13, 2023 | markets.businessinsider.comAkili Plans To Transform To Non-prescription Model; To Cut Workforce By Approx. 40%September 13, 2023 | marketbeat.comTrading was temporarily halted for "AKLI" at 07:09 AM with a stated reason of "News pending."August 14, 2023 | insidermonkey.comAkili, Inc. (NASDAQ:AKLI) Q2 2023 Earnings Call TranscriptAugust 10, 2023 | msn.comAkili, Inc. reports Q2 resultsJuly 10, 2023 | finance.yahoo.comAkili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ETJune 10, 2023 | markets.businessinsider.comAkili (AKLI) Receives a Buy from LifeSci CapitalJune 8, 2023 | finance.yahoo.comEndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adults Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Email Address What President Biden's new law means for investors (Ad)What's Got Musk, Bezos, and Gates So Excited? Billionaires are plowing millions of dollars into a new technology that early estimates say could generate more wealth than A.I. – and determine the future of companies like Microsoft. The problem? Most investors have no idea it's happening, or how to profit on it. This expert just went public with all the details, including which stocks to jump on immediately. AKLI Media Mentions By Week AKLI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKLI News Sentiment▼0.100.42▲Average Medical News Sentiment AKLI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKLI Articles This Week▼41▲AKLI Articles Average Week Get Akili News Delivered to You Automatically Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Co-Diagnostics News GBS News Retractable Technologies News Modular Medical News Femasys News NeuroOne Medical Technologies News Beyond Air News Spectral AI News SeaStar Medical News Carmell News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKLI) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsUrgent Nvidia WarningAltimetryDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akili, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
